SecurityRXI / iShares S&P Global Consumer Discretionary Sector Index Fund (464288745)
Institutional Owners62
Institutional Shares1,386,734
Institutional Value$ 153,636,000 USD

Institutional Stock Ownership and Shareholders

iShares S&P Global Consumer Discretionary Sector Index Fund (NYSE:RXI) has 62 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,386,734 shares. Largest shareholders include BlackRock Inc., Jane Street Group, Llc, Morgan Stanley, Newfound Research LLC, Commonwealth Equity Services, Llc., Commonwealth Equity Services, Inc, Bank Of America Corp /de/, Transamerica Financial Advisors, Inc., Citadel Advisors Llc, and TRUE Private Wealth Advisors.
iShares S&P Global Consumer Discretionary Sector Index Fund (NYSE:RXI) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-01-24 13F-HR IFP Advisors, Inc 103 0 -100.00 10 0 -100.00
2018-05-11 13F-HR CITIGROUP INC 3,066 3,066 0.00 335 342 2.09
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 63,562 59,916 -5.74 6,953 6,680 -3.93
2018-05-11 13F-HR MML INVESTORS SERVICES, LLC 1,963 2,723 38.72 215 304 41.40
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 1 1 0.00 0 0
2018-05-15 13F-HR Virtue Capital Management, Llc 155 226 45.81 17 26 52.94
2018-05-07 13F-HR Psagot Investment House Ltd. 10,500 10,500 0.00 1,149 1,171 1.91
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 17,979 16,933 -5.82 1,967 1,887 -4.07
2018-05-15 13F-HR UBS Group AG 10,636 11,084 4.21 1,163 1,236 6.28
2018-01-23 13F-HR Summit X, Llc 3,706 4,375 18.05 378 484 28.04
2018-04-16 13F-HR Westside Investment Management, Inc. 103 0 -100.00 11,638 0 -100.00
2018-04-23 13F-HR Advisory Services Network, LLC 65 65 0.00 7 7 0.00
2018-04-23 13F-HR Whitener Capital Management, Inc. 75 75 0.00 8 8 0.00
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 7,142 6,411 -10.24 781 715 -8.45
2018-05-15 13F-HR JANE STREET GROUP, LLC 31,148 171,807 451.58 3,407 19,153 462.17
2018-05-14 13F-HR Evercore Wealth Management, LLC 260 0 -100.00 28 0 -100.00
2018-05-07 13F-HR QUANTUM CAPITAL MANAGEMENT 3,715 3,651 -1.72 406 407 0.25
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 0 42,356 0 4,722
2018-05-10 13F-HR Stratos Wealth Partners, LTD. 225 225 0.00 25 25 0.00
2018-02-09 13F-HR Virtu Financial LLC 26,071 0 -100.00 2,655 0 -100.00
2018-05-04 13F-HR BABSON CAPITAL MANAGEMENT LLC 0 5,400 0 602
2018-04-23 13F-HR Brookstone Capital Management 8,737 14,058 60.90 956 1,567 63.91
2018-04-30 13F-HR BANK HAPOALIM BM 25,100 0 -100.00 2,746 0 -100.00
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 74,287 72,763 -2.05 7,352 7,409 0.78
2018-05-09 13F-HR Cambridge Investment Research Advisors, Inc. 4,471 5,650 26.37 489 630 28.83
2018-05-10 13F-HR BESSEMER GROUP INC 3,707 2,150 -42.00 406 240 -40.89
2018-05-15 13F-HR ADVANTAGE INVESTMENT MANAGEMENT, LLC 100 100 0.00 11 11 0.00
2018-05-15 13F-HR American Financial Network Advisory Services Llc 2,021 0 -100.00 221 0 -100.00
2018-05-15 13F-HR SCOTIA CAPITAL INC. 2,402 2,947 22.69 255 281 10.20
2018-02-12 13F-HR FIL Ltd 3,890 3,964 1.90 396 436 10.10
2018-05-15 13F-HR LPL Financial LLC 8,383 11,376 35.70 917 1,268 38.28
2018-02-15 13F-HR Bb&t Investment Services, Inc. 54 54 0.00 5 6 20.00
2018-02-14 13F-HR MILLENNIUM MANAGEMENT LLC 2,647 0 -100.00 270 0 -100.00
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 12,134 78,162 544.16 1,327 8,713 556.59
2018-02-14 13F-HR MORGAN STANLEY 82,612 102,068 23.55 8,413 11,165 32.71
2018-05-16 13F-HR Private Capital Group, Llc 379 379 0.00 41 42 2.44
2018-05-02 13F-HR Creative Financial Designs Inc /adv 503 503 0.00 55 56 1.82
2018-05-09 13F-HR ENVESTNET ASSET MANAGEMENT INC 9,832 9,555 -2.82 1,075 1,083 0.74
2018-05-04 13F-HR SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 825 1,100 33.33 90 123 36.67
2018-05-14 13F-HR NOMURA ASSET MANAGEMENT CO LTD 13,200 11,200 -15.15 1,444 1,249 -13.50
2018-04-26 13F-HR CWM, LLC 100 100 0.00 11 11 0.00
2018-05-14 13F-HR AMERIPRISE FINANCIAL INC 12,216 12,016 -1.64 1,336 1,339 0.22
2018-05-11 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 138 138 0.00 15 15 0.00
2018-05-15 13F-HR FIFTH THIRD BANCORP 6,600 5,029 -23.80 722 561 -22.30
2018-05-14 13F-HR InterOcean Capital, LLC 8,669 9,129 5.31 948 1,018 7.38
2018-05-11 13F-HR First Allied Advisory Services, Inc. 378 0 -100.00 41 0 -100.00
2018-05-15 13F-HR HighTower Advisors, LLC 1,832 204
2018-05-10 13F-HR Mirae Asset Global Investments Co., Ltd. 19,100 19,100 0.00 2,089 2,129 1.91
2018-05-01 13F-HR WHITTIER TRUST CO 1,200 1,200 0.00 131 134 2.29
2018-04-30 13F-HR GREENLEAF TRUST 38,783 32,550 -16.07 4,242 3,629 -14.45
2018-05-01 13F-HR WHITTIER TRUST CO OF NEVADA INC 1,500 1,500 0.00 164 167 1.83
2018-05-09 13F-HR BlackRock Inc. 362,797 372,823 2.76 39,686 41,562 4.73
2018-05-14 13F-HR Perigon Wealth Management, LLC 1,517 1,463 -3.56 166 163 -1.81
2018-05-11 13F-HR Slow Capital, Inc. 17,642 23,968 35.86 1,930 2,672 38.45
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 3,445 19,962 479.45 377 2,225 490.19
2018-01-24 13F-HR SG Americas Securities, LLC 20,426 0 -100.00 2,080 0 -100.00
2018-05-04 13F-HR Kcs Wealth Advisory 7,144 7,331 2.62 781 817 4.61
2018-04-19 13F-HR Janney Montgomery Scott LLC 2,241 1,899 -15.26 245 212 -13.47
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 19,001 24,891 31.00 2,079 2,775 33.48
2018-05-09 13F-HR OPTIMUM INVESTMENT ADVISORS 0 190 0 21
2018-05-09 13F-HR Transamerica Financial Advisors, Inc. 42,290 52,117 23.24 4,627 5,810 25.57
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 3,995 0 -100.00 437 0 -100.00
2018-02-12 13F-HR NN Investment Partners Holdings N.V. 301,756 0 -100.00 30,728 0 -100.00
2018-05-11 13F-HR TD Capital Management LLC 119 93 -21.85 13 10 -23.08
2018-05-03 13F-HR Newfound Research LLC 56,604 81,453 43.90 6,192 9,080 46.64
2018-04-16 13F-HR Raymond James Financial Services Advisors, Inc. 15,089 0 -100.00 1,651 0 -100.00
2018-05-10 13F-HR JP Morgan Chase & Co 0 75 0 8
2018-05-03 13F-HR WRAPMANAGER INC 12,089 20,502 69.59 1,322 2,286 72.92
2018-05-08 13F-HR US BANCORP \DE\ 40 40 0.00 4 4 0.00
2018-05-15 13F-HR Advisor Group, Inc. 1,133 1,429 26.13 124 159 28.23
2018-04-25 13F-HR TRUE Private Wealth Advisors 37,342 37,630 0.77 4,084 4,194 2.69
2018-05-21 13F-HR Front Row Advisors Llc 2,409 2,409 0.00 264 269 1.89
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 93 122 31.18 10 14 40.00
2018-05-14 13F-HR SUMITOMO MITSUI FINANCIAL GROUP, INC. 900 100

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 464288745